Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Dr. Xiaoquan Huang | Health and Medicine Advances | Research Excellence Award

Associate Researcher | Zhongshan Hospital, Fudan University | China

Dr. Xiaoquan Huang is an accomplished clinical researcher whose work centers on gastroenterology, hepatology, metabolic liver disease, portal hypertension, gastrointestinal bleeding, and global disease epidemiology. With 848 Scopus citations, 79 publications, and an h-index of 13, his research demonstrates sustained impact across Health Sciences, Pharmacology & Toxicology, Cardiology, Endocrinology, Geriatrics, Neurology, Psychiatry, Pulmonary Medicine, Radiology, and related clinical domains. His research portfolio features high-quality journal publications in Chinese Medical Journal, Journal of Gastroenterology and Hepatology, Thrombosis and Haemostasis, Endoscopy, Liver International, Therapeutic Advances in Chronic Disease, and Journal of Translational Medicine. His works span clinical investigations, systematic reviews, global burden analyses, and translational studies addressing cirrhosis-related complications, portal vein thrombosis, metabolic-associated fatty liver disease, and early-onset colorectal cancer. Dr. Xiaoquan Huang has also served as a corresponding author on several influential global epidemiology studies focused on colorectal cancer and fatty liver disease burden.  Dr. Xiaoquan Huang’s scholarly contributions include research on variceal bleeding management, endoscopic innovations, thrombosis prediction markers, myeloproliferative neoplasm-associated portal hypertension, and gastrointestinal microbiome trends. His findings have advanced evidence-based approaches for cirrhotic complications, individualized treatment strategies, endoscopic therapy optimization, and risk stratification in liver disease. He has contributed to meta-analyses and systematic reviews, including work on transoral incisionless fundoplication (TIF) for GERD and therapeutic evaluations in portal hypertension, expanding global clinical understanding and practice guidelines. His research awards include multiple Young Investigator accolades from APDW, EASL, and JGHF, reflecting international recognition for innovation and research excellence. Dr. Xiaoquan Huang’s academic leadership includes reviewer service, conference presentations, and contributions to collaborative global research projects. His ongoing work continues to shape diagnostic, therapeutic, and epidemiological frameworks in hepatology and gastroenterology, establishing him as a significant contributor to clinical research and patient-centered innovations.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles

Featured Publications

1. Huang, X., Zou, D., Wang, H., Chen, W., Zhang, L., Li, F., Ma, L., Zhang, C., Chen, Y., & Chen, S. (2024). Gastric variceal obstruction improves the efficacy of endoscopic management of esophageal variceal bleeding in GOV type I. Endoscopy International Open, 12(8), E940–E946.

2. Wang, Y., Huang, X. (Corresponding author), Cheryala, M., Aloysius, M., Zheng, B., Yang, K., Chen, B., Fang, Q., Chowdary, S. B., Abougergi, M. S., & Chen, S. (2023). Global increase of colorectal cancer in young adults over the last 30 years: An analysis of the Global Burden of Disease Study 2019. Journal of Gastroenterology and Hepatology, 38(9), 1552–1558.

3. Jiang, S., Ai, Y., Fan, X., Huang, X. (Corresponding author), Wu, L., Ni, L., Li, F., & Chen, S. (2023). Increased factor VIII activity is predictive of the occurrence of portal vein thrombosis in cirrhosis. Thrombosis and Haemostasis, 123(7), 714–722.

4. Huang, X., Zhang, M., Ai, Y., Jiang, S., Xiao, M., Wang, L., Jian, Y., Zhuge, Y., Zhang, C., & Chen, S. (2022). Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Therapeutic Advances in Chronic Disease, 13, Article 20406223221125691.

5. Huang, X., Abougergi, M. S., Sun, C., Murphy, D., Sondhi, V., Chen, B., Zheng, X., Chen, S., & Wang, Y. (2023). Incidence and outcomes of thromboembolic and bleeding events in patients with liver cirrhosis in the USA. Liver International, 43(2), 434–441.

Yiling Hou | Health and Medicine | Best Researcher Award

Prof. Dr. Yiling Hou | Health and Medicine | Best Researcher Award

Professor, China West Normal University, China

Prof. Dr. Yiling Hou is a distinguished scientist and Professor at the College of Life Sciences, China West Normal University, recognized as a reserve candidate for academic and technological leadership in Sichuan Province and an overseas high-level talent. She earned her Bachelor of Science in Pharmacy (2005) and Master of Science in Medicinal Chemistry (2008) from Sichuan University, followed by a Doctor of Science in Biochemistry and Molecular Biology (2011) from Sichuan Agricultural University and further enhanced her expertise as a visiting scholar at the Perelman School of Medicine, University of Pennsylvania (2017–2018). Beginning her career as a Teaching Assistant in 2008, she advanced to Lecturer in 2011, Associate Professor in 2011 and full Professor in 2016, also serving as Program Director for Biotechnology (2013–2020) and currently as Deputy Director of the Sichuan Collaborative Innovation Center for Tissue Repair Materials Engineering Technology. Her research focuses on the isolation, purification, structural identification and biological activity of fungal polysaccharides, alongside tumor cell kinetics, spindle dynamics during mitosis, meiosis and the molecular mechanisms underlying cancer progression. Skilled in structural identification, molecular medicine, apoptosis analysis and advanced biopharmaceutical techniques, she has published 104 Scopus-indexed papers with 787 citations and an h-index of 16, reflecting her growing international impact. Prof. Dr. Yiling Hou is an active Councilor of the Sichuan Provincial Microbiology Society and the Sichuan Provincial Youth Federation, highlighting her commitment to scientific community leadership and youth engagement. Honored as an emerging academic leader in Sichuan Province, she continues to guide students and collaborative projects that bridge traditional pharmacology and modern oncology. With her strong publication record, leadership roles and global collaborations, Prof. Dr. Yiling Hou is poised to make transformative contributions to cancer research and molecular therapeutics, advancing biomedical science and inspiring future generations of researchers.

Profile: Scopus | ResearchGate | Sci Profiles | Scilit

Featured Publications

1. Wang, Y., Lu, R., Ding, X., You, Y., Lin, Y., Hou, Y., & Xia, Y. (2025). Structure identification and in vitro immunomodulatory activities of polysaccharide AHL26-P from Arachis hypogaea (Tianfu 26) leaves. Results in Chemistry, 18, 102724.

2. Sun, Z.-A., Zhao, N., Zheng, L., Pan, F., Ding, X., & Hou, Y. (2025, June 26). Comparative studies on the structure and biological activities of two new polysaccharides from Tricholoma flavovirens (TF-P) and Trametes versicolor (TV-P). Results in Chemistry. Advance online publication.

3. Liu, K., Sun, Z., Li, X., Qing, X., Yu, W., Liu, M., Ding, X., & Hou, Y. (2025). Structure characterization and biological activity of polysaccharides from Trametes sanguinea (TS-P) and wild Lentinus edodes (LE-P). Food Bioscience, 68, 106656.

4. Zhou, L., Ding, X., & Hou, Y. (2024). The structure characterization and biological activities of new polysaccharides from Armillariella tabescens (AT-P) and Tricholoma portentosum (TP-P). Results in Chemistry, 18, 4620–4633.

5. Yu, W., Yuan, R., Liu, M., Liu, K., Ding, X., & Hou, Y. (2024). Effects of rpl1001 gene deletion on cell division of fission yeast and its molecular mechanism. Current Issues in Molecular Biology, 46(3), 2576–2597.